CORDIS · 249306 · FP7
REALIGNMENT Realignment: ENHANCING IMPLANT PERFORMANCE THROUGH STRUCTURAL REARRANGEMENTS IN HYDROXYAPATITE
Coordinator: RIGAS TEHNISKA UNIVERSITATE (LV)
Hydroxyapatite is used extensively in orthopaedic implants, and has benefited from the known biocompatibility of apatites within teeth and bone. Continual material development is hindered from several factors. One of these is the unknown influence of structural modifications on the properties. The variability of properties is, in part, attributed to the flexibility to permit atom vacancies and accommodate lower hydroxyl contents. This project will assess the impact of dehydroxylation on material properties (mechanical properties, solubility, charge) and cell response. The range of solid solut…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
EU contribution: €100k awarded to the consortium. The project runs over approximately 4 years from 2010-02-01 to 2014-01-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from LV
see all →- VIOBOND — VIOBOND – sustainable binder: Upscaling new lignin-phenol-formaldehyde resin production with wood-based biorefinery lignin101022987 · H2020 · €15.9M
- PMPC — Centre of Excellence for Precision Medicine in Pediatric Care101136530 · HORIZON · €14.4M
- INNOVABALT — Strengthening the research and innovation capacities of the Latvian Institute of Organic Synthesis, the leading Baltic regional centre for drug discovery316149 · FP7 · €4.7M
- CIRCLEUP — 100 Households, 100 Circular Stories: Inspiring Sustainable Living in Europe101135495 · HORIZON · €4.6M
- FOTONIKA- LV — Unlocking and Boosting Research Potential for Photonics in Latvia – Towards Effective Integration in the European Research Area285912 · FP7 · €3.8M
- BioMagnetLink — Biological magnets as a unifying link to multidisciplinary research excellence101187789 · HORIZON · €2.6M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the MC-IRG funding scheme.
- What is the EU contribution?
- The European Commission contributes €100k toward a total project budget of €100k.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by RIGAS TEHNISKA UNIVERSITATE (LV).
- What is the project timeline?
- The project runs from 2010-02-01 to 2014-01-31 — approximately 4 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 249306.